GLP-1 weight-loss drug, whose full name is Glucagon-like peptide-1 receptor agonist. Initially, GLP-1 was a hormone secreted by the gastrointestinal tract mainly used for treating diabetes, but it has also been used to suppress appetite and control weight.
Top SA Quant-rated Medical Devices Stocks as Technicals Look Strong
Live Stock: Stargate Rivals the Scale of the Manhattan Project, Musk Said it's a Pipe Dream
IMMvention Therapeutix Enters Collaboration With Novo Nordisk for Sickle Cell Disease Therapies
Top 3 Health Care Stocks That Could Blast Off This Quarter
Google Parent-Owned Startup To Launch AI-Designed Drug Trials By Year-End, Partnering With Eli Lilly And Novartis To Tackle Major Diseases
The speed of drug research and development has increased by ten times! Google states that the first AI-designed medication will enter testing by the end of the year.
Demis Hassabis, the founder of Google's drug development company, stated that traditional drug development usually takes 5 to 10 years, while with the help of AI technology, this process may be accelerated by 10 times. Former USA Treasury Secretary Summers once commented that AI's relationship with the Internet Plus-Related is similar to that of computers with calculators.